glp 1 long term studies GLP‐1 Agonists for Pediatric Psychopharmacology: Opportunities and Cautions - Bartkoski - 2025 - Clinical and Translational Science Discover How GLP-1 Trials Are

GLP-1s are a bottom-up approach, using gut hormones to create a natural feeling of fullness and metabolic balance

Regulatory and Insurance Changes: The approval of the first oral GLP-1 (Dec 2025) with explicit labeling for obesity (and overweight with comorbidities) ( [25] ) ( [67] ) will likely broaden insurance coverage scenarios

You will start with lower doses for the first 4 weeks of treatment to help reduce initial stomach side effects, but this is not an effective dose to lower blood sugar over the long-term

Many people expect the hard part to end at goal weight

Truth: Maintaining muscle mass is possible with the right nutrition and exercise